Articles written by: Tammy James

Reviewing Genocea Biosciences Inc. (GNCA)’s and Prana Biotechnology Ltd (:)’s results

Genocea Biosciences Inc. (NASDAQ:GNCA) and Prana Biotechnology Ltd (:), both competing one another are Biotechnology companies. We will compare their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings and valuation. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Genocea Biosciences Inc. 3 0.00 13.39M […]

Mimecast Limited (MIME)’s Financial Results Comparing With Pluralsight Inc. (NASDAQ:PS)

Both Mimecast Limited (NASDAQ:MIME) and Pluralsight Inc. (NASDAQ:PS) are Application Software companies, competing one another. We will compare their profitability, analyst recommendations, institutional ownership, risk, dividends, earnings and valuation. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Mimecast Limited 40 1.29 48.48M -0.12 0.00 […]

Reviewing Bridge Bancorp Inc. (BDGE)’s and Mid Penn Bancorp Inc. (NASDAQ:MPB)’s results

Bridge Bancorp Inc. (NASDAQ:BDGE) and Mid Penn Bancorp Inc. (NASDAQ:MPB) compete against each other in the Regional – Northeast Banks sector. We will contrast them and contrast their analyst recommendations, profitability, risk, dividends, institutional ownership, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share […]

Comparing of Reata Pharmaceuticals Inc. (RETA) and Oncolytics Biotech Inc. (NASDAQ:ONCY)

Both Reata Pharmaceuticals Inc. (NASDAQ:RETA) and Oncolytics Biotech Inc. (NASDAQ:ONCY) are each other’s competitor in the Biotechnology industry. Thus the compare of their risk, analyst recommendations, institutional ownership, profitability, dividends, earnings and valuation. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Reata Pharmaceuticals Inc. […]

Insmed Incorporated (INSM)’s Financial Results Comparing With Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Both Insmed Incorporated (NASDAQ:INSM) and Jazz Pharmaceuticals plc (NASDAQ:JAZZ) are each other’s competitor in the Biotechnology industry. Thus the contrast of their dividends, institutional ownership, analyst recommendations, profitability, risk, earnings and valuation. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Insmed Incorporated 18 0.00 […]

Contrasting of Pacific Biosciences of California Inc. (PACB) and Novo Nordisk A/S (NYSE:NVO)

As Biotechnology companies, Pacific Biosciences of California Inc. (NASDAQ:PACB) and Novo Nordisk A/S (NYSE:NVO) are our subject to contrast. And more specifically their profitability, analyst recommendations, risk, dividends, institutional ownership, earnings and valuation. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Pacific Biosciences of […]

Comparison of Wright Medical Group N.V. (WMGI) and Align Technology Inc. (NASDAQ:ALGN)

Both Wright Medical Group N.V. (NASDAQ:WMGI) and Align Technology Inc. (NASDAQ:ALGN) compete on a level playing field in the Medical Appliances & Equipment industry. We will evaluate their performance with regards to profitability, analyst recommendations, institutional ownership, risk, dividends, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net […]

Nektar Therapeutics (NKTR)’s Financial Results Comparing With Corcept Therapeutics Incorporated (NASDAQ:CORT)

Both Nektar Therapeutics (NASDAQ:NKTR) and Corcept Therapeutics Incorporated (NASDAQ:CORT) are each other’s competitor in the Biotechnology industry. Thus the compare of their dividends, institutional ownership, analyst recommendations, profitability, risk, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Nektar Therapeutics 18 0.98 […]